New York Launches New COVID-19 Drug Trials; More Underway in China

March 24, 2020

(UPI) – New York, “ground zero” for the U.S. coronavirus outbreak, is taking the lead on drug testing, with trials beginning this week on three drugs believed to have potential for treatment. Trials to assess the efficacy and safety of the anti-malaria drug chloroquine, its sister agent hydroxychloroquine and the antibiotic azithromycin will join trials of other drugs going on globally, including tests of an HIV drug and an antiviral.